SEC Form 4 · accession 0001209191-18-058536
Verrica Pharmaceuticals Inc. · VRCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul B Manning
Director · 10% Owner
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660334
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 12, 2018 | P | 5,150 | $13.17 | A | 7,992,933 | D | |
| Common StockF1,F3 | Nov 12, 2018 | P | 5,150 | $13.17 | A | 1,265,394 | I | See Footnote |
| Common StockF4,F5 | Nov 12, 2018 | P | 9,950 | $13.96 | A | 8,002,883 | D | |
| Common StockF4,F3 | Nov 12, 2018 | P | 9,950 | $13.96 | A | 1,275,344 | I | See Footnote |
| Common StockF6,F7 | Nov 13, 2018 | P | 10,527 | $14.08 | A | 8,013,410 | D | |
| Common StockF6,F3 | Nov 13, 2018 | P | 10,527 | $14.08 | A | 1,285,871 | I | See Footnote |
| Common StockF8,F9 | Nov 13, 2018 | P | 9,418 | $14.94 | A | 8,022,828 | D | |
| Common StockF8,F3 | Nov 13, 2018 | P | 9,418 | $14.94 | A | 1,295,289 | I | See Footnote |
| Common StockF10,F11 | Nov 13, 2018 | P | 55 | $15.60 | A | 8,022,883 | D | |
| Common StockF10,F3 | Nov 13, 2018 | P | 55 | $15.60 | A | 1,295,344 | I | See Footnote |
| Common StockF12 | holding | — | — | — | 256,634 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $12.615 to $13.60, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F10This transaction was executed in multiple trades at prices ranging from $15.55 to $15.60, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F11Consists of 7,754,783 shares of common stock held by Mr. Manning and 268,100 shares of common stock held by Mr. Manning jointly with his spouse.
- F12The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is President and CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.
- F2Consists of 7,754,783 shares of common stock held by Mr. Manning and 238,150 shares of common stock held by Mr. Manning jointly with his spouse.
- F3The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and has sole voting and investment power with respect to the shares held by BKB.
- F4This transaction was executed in multiple trades at prices ranging from $13.70 to $14.31, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F5Consists of 7,754,783 shares of common stock held by Mr. Manning and 248,100 shares of common stock held by Mr. Manning jointly with his spouse.
- F6This transaction was executed in multiple trades at prices ranging from $13.50 to $14.47, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F7Consists of 7,754,783 shares of common stock held by Mr. Manning and 258,627 shares of common stock held by Mr. Manning jointly with his spouse.
- F8This transaction was executed in multiple trades at prices ranging from $14.50 to $15.36, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F9Consists of 7,754,783 shares of common stock held by Mr. Manning and 268,045 shares of common stock held by Mr. Manning jointly with his spouse.